Status
Conditions
Treatments
About
Sodium DNA has several properties that may be beneficial in the management of bacterial biofilm in periodontitis. The aim of this RCT study is to clinically evaluate the antimicrobial and oral biofilm control properties of two mouthwashes containing Chlorhexidine 0.12% + Sodium DNA and Chlorhexidine 0.20% at two weeks, compared with a placebo, on patients with stage III or IV periodontitis.
Full description
Sodium DNA has several properties that may be beneficial in the management of bacterial biofilm in periodontitis. The aim of this RCTstudy is to clinically evaluate the antimicrobial and oral biofilm control properties of two mouthwashes containing Chlorhexidine 0.12% + Sodium DNA and Chlorhexidine 0.20% at two weeks, compared with a placebo, on patients with stage III or IV periodontitis. The study was designed as a double-blind randomized controlled trial (RCT) with three parallel groups of individuals.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
• Clinically diagnosed with stage III or IV periodontitis according to the EFP/AAP 2017 criteria.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
56 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Gaetano Prof. Isola, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal